EME - 12/165/31

Targeting vascular adhesion protein-1 (VAP-1) for the treatment of liver fibrosis: a study of efficacy and mechanisms in patients with primary sclerosing cholangitis (PSC)

Project title: Targeting vascular adhesion protein-1 (VAP-1) for the treatment of liver fibrosis: a study of efficacy and mechanisms in patients with primary sclerosing cholangitis (PSC)

Call to action: 12/165 12/165 Disorders of fibrosis

Research type: Primary Research

Chief investigator: Professor Philip Newsome

Lead Author: Dr Katherine Arndtz

Contractor: University of Birmingham

Cost: £489,233.75

Co-investigators: Dr Roger Chapman, Mr Darren Barton, Mr David Smith, Mr Richard Fox, Professor David Adams, Professor Eleanor Barnes, Professor Jonathan Deeks.

Started: January 2015 | Status: Published March 2022

ISRCTN: 11233255

This trial did not show any evidence of efficacy of BTT1023 and as per the protocol and the design of the trial it was discontinued.

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.